These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12636170)

  • 41. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
    Mason RP; Moisey DM; Shajenko L
    Mol Pharmacol; 1992 Feb; 41(2):315-21. PubMed ID: 1531693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between lipophilicities of 1,4-dihydropyridine derivatives and pharmacokinetic interaction strengths with grapefruit juice.
    Uesawa Y; Mohri K
    Yakugaku Zasshi; 2008 Jan; 128(1):117-22. PubMed ID: 18176062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inclusion complexes of nifedipine and other 1.4-dihydropyridine derivatives with cyclodextrins. IV. The UV study on photochemical stability of the inclusion complexes of nisoldipine, nimodipine, nitrendipine and nicardipine with beta-cyclodextrin in the solution.
    Mielcarek J
    Acta Pol Pharm; 1995; 52(6):459-63. PubMed ID: 8960264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.
    Bourson A; Moser PC
    Psychopharmacology (Berl); 1990; 100(2):168-72. PubMed ID: 1689500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a new copper(II)-curcumin complex as superoxide dismutase mimic and its free radical reactions.
    Barik A; Mishra B; Shen L; Mohan H; Kadam RM; Dutta S; Zhang HY; Priyadarsini KI
    Free Radic Biol Med; 2005 Sep; 39(6):811-22. PubMed ID: 16109310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dual effect of dihydropyridines on 45Ca uptake induced by the K+ -channel blocker, 4-aminopyridin on mast cells.
    Eleno N; Botana L; Espinosa J
    J Cell Physiol; 1988 Nov; 137(2):378-83. PubMed ID: 2461378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different antioxidative potencies of dihydropyridine calcium channel modulators in various models.
    Berkels R; Breitenbach T; Bartels H; Taubert D; Rosenkranz A; Klaus W; Roesen R
    Vascul Pharmacol; 2005 Mar; 42(4):145-52. PubMed ID: 15820440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, Evaluation of Pharmacological Activity, and Molecular Docking of 1,4-Dihydropyridines as Calcium Antagonists.
    Shaldam MA; El-Hamamsy MH; Saleh DO; El-Moselhy TF
    Chem Pharm Bull (Tokyo); 2016; 64(4):297-304. PubMed ID: 26822207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors.
    Choi SJ; Cho JH; Im I; Lee SD; Jang JY; Oh YM; Jung YK; Jeon ES; Kim YC
    Eur J Med Chem; 2010 Jun; 45(6):2578-90. PubMed ID: 20303626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On the mechanism of action of fullerene derivatives in superoxide dismutation.
    Osuna S; Swart M; Solà M
    Chemistry; 2010 Mar; 16(10):3207-14. PubMed ID: 20119990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attenuation of myocardial reperfusion injury by reducing intracellular calcium overloading with dihydropyridines.
    Liu X; Engelman RM; Wei Z; Bagchi D; Rousou JA; Nath D; Das DK
    Biochem Pharmacol; 1993 Mar; 45(6):1333-41. PubMed ID: 8466553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contribution of Molecular Structure to Self-Assembling and Biological Properties of Bifunctional Lipid-Like 4-(
    Rucins M; Dimitrijevs P; Pajuste K; Petrichenko O; Jackevica L; Gulbe A; Kibilda S; Smits K; Plotniece M; Tirzite D; Pajuste K; Sobolev A; Liepins J; Domracheva I; Plotniece A
    Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30871041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers.
    El-Moselhy TF; Sidhom PA; Esmat EA; El-Mahdy NA
    Chem Pharm Bull (Tokyo); 2017; 65(10):893-903. PubMed ID: 28966273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effects of three 1,4-dihydropyridine derivatives [OSI-1210, OSI-1211 (etaftoron), and OSI-3802] on rat liver mitochondrial bioenergetics and on the physical properties of membrane lipid bilayers: relevance to the length of the alkoxyl chain in positions 3 and 5 of the DHP ring.
    Fernandes MA; Pereira SP; Jurado AS; Custódio JB; Santos MS; Moreno AJ; Duburs G; Vicente JA
    Chem Biol Interact; 2008 Jun; 173(3):195-204. PubMed ID: 18452904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An antibody to dihydropyridine calcium entry blockers. A comparison with the calcium channel receptor in skeletal muscle.
    Thayer SA; Pham DH; Schultz CM; Minaskanian G; Fairhurst AS
    Biochem Pharmacol; 1986 Dec; 35(24):4479-85. PubMed ID: 3024651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of new and known 1,4-dihydropyridine derivatives on blood glucose levels in normal and streptozotocin-induced diabetic rats.
    Briede J; Stivriņa M; Stoldere D; Bisenieks E; Uldriķis J; Poikāns J; Makarova N; Duburs G
    Cell Biochem Funct; 2004; 22(4):219-24. PubMed ID: 15248181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma concentration-response relationships for some cardiovascular effects of dihydropyridines in healthy subjects.
    Graefe KH; Ziegler R; Wingender W; Rämsch KD; Schmitz H
    Clin Pharmacol Ther; 1988 Jan; 43(1):16-22. PubMed ID: 3335117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
    Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
    Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Species differences in the negative inotropic response of 1,4-dihydropyridine calcium channel blockers in myocardium.
    Boyd RA; Giacomini JC; Giacomini KM
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):650-7. PubMed ID: 2467082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.